US developer Tishman Speyer has signed pharmaceutical company Ipsen Biopharm for 18,000-square-foot The Point office in Paddington in London.
US developer Tishman Speyer has signed pharmaceutical company Ipsen Biopharm for 18,000-square-foot The Point office in Paddington in London.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
37 North Wharf Rd, London, LND
Real Estate